This study identifies serum miRNA signatures as promising biomarkers for Alzheimer’s, enhancing prediction of MCI conversion to AD with clinical relevance.
This study identifies serum miRNA signatures as promising biomarkers for Alzheimer’s, enhancing prediction of MCI conversion to AD with clinical relevance.